Issue Date: May 9, 2011
Dendrimer Treats Joint Inflammation
For sufferers of rheumatoid arthritis—the chronic inflammatory disease that induces pain, swelling, and eventual deformity in the joints of about 1% of the world’s population—more effective treatment could be on the way. Current medicines for the crippling disease typically target a signaling protein in the inflammatory pathway but don’t prevent eventual erosion of the bones in patients’ joints. Now, a research team led by Jean-Luc Davignon and Rémy Poupot of France’s National Institute . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society